Association between Omentin Levels and Insulin Resistance in Pregnancy


Aktas G., Alcelik A., Ozlu T., Tosun M., Tekce B. K., Savli H., ...More

EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, vol.122, no.3, pp.163-166, 2014 (SCI-Expanded) identifier

  • Publication Type: Article / Article
  • Volume: 122 Issue: 3
  • Publication Date: 2014
  • Doi Number: 10.1055/s-0034-1370917
  • Journal Name: EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.163-166
  • Keywords: omentin, insulin resistance, pregnancy, POLYCYSTIC-OVARY-SYNDROME, ADIPOSE-TISSUE, INFLAMMATION, ADIPOKINE, OBESITY, DISEASE, WOMEN
  • Istanbul University Affiliated: No

Abstract

Aims: Omentin is a new adipokine secreted mainly from visceral adipose tissue. Serum omentin is found to be reduced in patients with impaired glucose tolerance, type 2 diabetes mellitus, obesity and insulin resistant states. Despite the fact that pregnancy is also characterized with hyperinsulinemia, literature is lacking about data of omentin levels and its association with insulin resistance in pregnant women. We aimed to evaluate the association of omentin levels and insulin resistance in pregnant women and to compare these levels with those of non-pregnant, nondiabetic women.